Stocks
Cara Therapeutics (CARA) FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | -60.1 | -78.8 | -94.5 | -62.0 | -23.5 | -24.7 | ||
| Changes by years, y/y, % | +930% | +31% | +20% | -34% | -62% | +32.1% | |||
Cara Therapeutics. FCF, bln rub
Cara Therapeutics. FCF, changes, %
Cara Therapeutics. FCF, sum by quarters, bln rub
Cara Therapeutics (CARA) FCF US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| FCF, bln rub | ? | -8.87 | -4.26 | -5.69 | -5.86 | -9.23 | -24.7 | |
| Changes by years, y/y, % | -30% | -70% | +41% | +25% | +4% | |||
| Changes by quarters, q/q, % | +89% | -52% | +34% | +3% | +58% | |||
